Given that the interaction between miRNA and virus materials has been established in various diseases, some miRNAs, which can target capsid protein-coding genes of the virus or ACE2, may be used as a therapeutic solution to inhibit or attenuate COVID-19. The gene discussed is ACE2; the disease is COVID-19.